- AIMS Scale
- Clinical Practice Guidelines
- Drug Interactions
- Harvard Psychopharmacology Algorithm Project
- MAOI Diet
- Prescription Drug Patient Assistance Programs
- Psychopharmacology Tips
- Schizophrenia Treatment ("PORT")
This site contains a standard approach, the AIMS, for the clinical assessment of patients who may have involuntary movement disorders (from antipsychotic medications) and may have tardive dyskinesia.
Medication guidelines from various organizations and for many diagnostic conditions.
Presents, in table form, Clinically Used Drugs Metabolized by Cytochrome P450
Psychopharmacology Algorithm Project
The main aim of this project is to improve the quality of psychopharmacological thinking and care by promoting evidence-based practice especially through the use of computerized algorithms. The evidence considered includes high quality empirical research studies but also uncontrolled studies and compilations of expert opinion and practice guidelines. The Project's algorithms provide a base of knowledge for determination of what is best for a particular patient. They are not a set of steps to memorize and use without deviation.I
Includes information about the special dietary precautions for patients on MAOI medications for depression.
Prescription Drug Patient Assistance
Offers help in obtaining medications without charge or with reduced charges. Most are through the pharmaceutical companies' indigent programs.
Information about medications.
Article, from Schizophrenia Bulletin, contains a very specific and comprehensive set of treatment guidelines for schizophrenia (referred to as "PORT" recommendations from the "Patient Outcomes Research Team" funded by NIMH). Eighteen of the recommendations address antipsychotic agents and adjunctive pharmacotherapies; the remaining 12 address electroconvulsive therapy, psychological interventions, family interventions, vocational rehabilitation, and assertive community treatment/intensive case management.